NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

NextCure's Return on Capital Employed [ROCE] came in at -350.04% for Q3 2026, down 165.34 percentage points from -184.70% a year earlier and down 166.24 percentage points from the prior quarter.

Analysis

NextCure (NXTC) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, NextCure's Return on Capital Employed [ROCE] was -104.84%, down 41.87 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last five years, with a five-year change of -92.00 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -62.98% in FY2024 (-17.65 pp), -45.33% in FY2023 (-8.14 pp), -37.18% in FY2022 (-10.77 pp) and -26.41% in FY2021 (-13.57 pp).
  • The Q3 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2019.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for 23 consecutive quarters, with an average year-over-year change of -74.80 percentage points over the last eight quarters.
  • The year-over-year drop in Return on Capital Employed [ROCE] has ranged between 9.69 percentage points (Q1 2023) and 165.34 percentage points (Q3 2026) over the last five years.
  • Business Quant data shows NXTC's Return on Capital Employed [ROCE] at -183.80% (Q2 2026), -150.85% (Q1 2026) and -167.82% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 NextCure 29.30 Mn -71.08 Mn - -350.04%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -350.04%
Jun 30, 2026 -183.80%
Mar 31, 2026 -150.85%
Dec 31, 2025 -167.82%
Sep 30, 2025 -184.70%
Jun 30, 2025 -136.95%
Mar 31, 2025 -77.74%
Dec 31, 2024 -78.59%
Sep 30, 2024 -71.85%
Jun 30, 2024 -67.53%
Mar 31, 2024 -61.48%
Dec 31, 2023 -53.21%
Sep 30, 2023 -49.69%
Jun 30, 2023 -47.94%
Mar 31, 2023 -42.55%
Dec 31, 2022 -42.67%
Sep 30, 2022 -39.12%
Jun 30, 2022 -35.66%
Mar 31, 2022 -32.86%
Dec 31, 2021 -29.06%
API Access

NextCure Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NXTC&period=max&api_key=YOUR_API_KEY